Relationship between Adiponectin and Metabolic Variables in Caribbean Offspring of Patients with Type 2 Diabetes Mellitus

 

 Buy Article Permissions and Reprints

Abstract

Aim: To examine the relationship between adiponectin and metabolic variables in the offspring of patients with type 2 diabetes mellitus. Methods: Fasting blood samples and anthropometric indices were taken from 34 subjects, offspring of patients with type 2 diabetes, and 24 healthy control subjects without any immediate family history of diabetes. Plasma glucose and serum adiponectin, insulin, triglycerides, total cholesterol, HDL and LDL cholesterol levels were measured, and insulin resistance (IR) was calculated based on the homeostasis model assessment (HOMA) method. Results: Offspring and control subjects were sex-matched, but the offspring were older and had higher body mass index and waist circumference than the control subjects (p < 0.05). The offspring had significantly higher mean fasting plasma glucose concentrations; however, their mean serum insulin, adiponectin, triglyceride, total cholesterol, HDL and LDL cholesterol and HOMA-derived IR levels did not significantly differ from those of the control subjects (p > 0.05). While the negative correlation between serum adiponectin and HDL cholesterol levels in the offspring remained statistically significant after adjusting for the effect of age, sex and BMI (r = - 0.37, p < 0.05), the negative correlation between adiponectin and serum triglyceride, LDL cholesterol or IR levels became non-significant after controlling for the above variables (p > 0.05 in all cases). Conclusion: The correlation between adiponectin and some known biochemical risk factors for developing diabetes and cardiovascular disease in the offspring of patients with diabetes warrants further study to evaluate its potential in assessing the risk of developing these disorders.

References

• 1 Barnett A H, Effo C, Leslie R D, Pyke D A. Diabetes in identical twins: a study of 200 pairs.  Diabetologia. 1981;  20 87-93
  CrossrefPubMedGoogle Scholar
• 2 Newman B, Sleby J V, King M C, Slemenda C, Fabsitz P, Friedman C D. Concordance for type 2 (NIDDM) diabetes in male twins.  Diabetologia. 1987;  30 763-768
  PubMedGoogle Scholar
• 3 Haffner S M, Stern M P, Hazuda H P, Mitchel B D, Patterson J K. Increased insulin concentration in non-diabetic offspring of diabetic parents.  N Engl J Med. 1988;  319 1297-1301
  PubMedGoogle Scholar
• 4 Warram J H, Blaise C M, Andrez S, Soeldner J S, Kahn C R. Slow glucose removal rate and hyperinsulinaemia precede the development of type II diabetes in the offspring of diabetic parents.  Ann Int Med. 1990;  113 909-915
  PubMedGoogle Scholar
• 5 Eriksson J E, Franssila K A, Ekstrand C S, Widen W, Schalin C. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl.  J Med. 1989;  320 337-343
  PubMedGoogle Scholar
• 6 Osei K. Increased basal glucose production and utilisation in non-diabetic first-degree relatives of patients with NIDDM.  Diabetes. 1990;  39 597-601
  PubMedGoogle Scholar
• 7 Gaillard T R, Schuster D P, Bossetti B M, Green P A, Osei K. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes: implications for syndrome X.  Diabetes Care. 1997;  20 745-752
  CrossrefPubMedGoogle Scholar
• 8 Ezenwaka C E, Akanji A O, Osei K, Adejuwon C A, O’Dorisio T M, Cotrell D A, Akinlade K S. Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin dependent diabetes mellitus.  Diabetes Res Clin Pract. 1993;  20 175-181
  CrossrefPubMedGoogle Scholar
• 9 Snethalatha c, Ramachandran A, Satyavani K, Latha E, Viswanathan V. Study of genetic prediabetic South Indian subjects: importance of hyperinsulinemia and B-cell dysfunction.  Diabetes Care. 1998;  21 76-79
  PubMedGoogle Scholar
• 10 Ezenwaka C E, Davis G, Offiah N V. Insulin secretion in glucose-tolerant offspring of type 2 diabetes patients in Trinidad, West Indies.  Southern Med J. 2001;  94 223-228
  PubMedGoogle Scholar
• 11 Stewart M W, Humphriss D B, Berrish T S, Barriocanal L A, Trajano L R, Alberti K G, Walker M. Features of syndrome X in first-degree relatives of NIDDM patients.  Diabetes Care. 1995;  18 1020-1022
  PubMedGoogle Scholar
• 12 Ezenwaka C E, Davis G, Offiah N V. Evaluation of features of syndrome X in offspring of Caribbean patients with type 2 diabetes.  Scand J Clin Lab Invest. 2001;  61 19-26
  PubMedGoogle Scholar
• 13 Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study.  Diabetes Care. 2003;  26 2015-2020
  CrossrefPubMedGoogle Scholar
• 14 Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley R E, Tataranni P A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.  J Clin Endocrinol Metab. 2001;  86 1930-1935
  CrossrefPubMedGoogle Scholar
• 15 Zietz B, Herfarth H, Paul G, Ehling A, Muller-Ladner U, Scholmerich J, Schaffler A. Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes.  FEBS Lett.. 2003;  545 103-104
  CrossrefPubMedGoogle Scholar
• 16 Pellme F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, Taskinen M R, Jansson P A. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.  Diabetes. 2003;  52 1182-1186
  PubMedGoogle Scholar
• 17 Valsamakis G, Chetty R, McTernan P G, Al-Daghri N M, Barnett A H, Kumar S. Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol.  Diabetes Obes Metab. 2003;  25 31-135
  PubMedGoogle Scholar
• 18 Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, Ueda S, Shimomura I, Funahashi T, Matsuzawa Y. Hypoadiponectinemia is closely linked to endothelial dysfunction in man.  J Clin Endocrinol Metab. 2003;  88 3236-3240
  CrossrefPubMedGoogle Scholar
• 19 Heilbronn L K, Smith S R, Ravussin E. The insulin-sensitizing role of the fat derived hormone adiponectin.  Curr Pharm Des.. 2003;  9 1411-1418
  CrossrefPubMedGoogle Scholar
• 20 Diez J J, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease.  Eur J Endocrinol.. 2003;  148 293-300
  CrossrefPubMedGoogle Scholar
• 21 Stefan N, Stumvoll M. Adiponectin - its role in metabolism and beyond.  Horm Metab Res.. 2002;  34 469-474
  Article in Thieme ConnectPubMedGoogle Scholar
• 22 Amos A F, McCarty D J, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010.  Diabet Med. 1997;  14 (Suppl. 5) S7-S85
  CrossrefPubMedGoogle Scholar
• 23 Friedwald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein in plasma without use of preparative ultracentrifuge.  Clin Chem. 1972;  18 499-502
  CrossrefPubMedGoogle Scholar
• 24 Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
  Google Scholar
• 25 DeFronzo R A, Simonson D, Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.  Diabetologia.. 1982;  23 313-319
  PubMedGoogle Scholar
• 26 Hotta K, Funahashi T, Bodkin N L, Ortmeyer H K, Arita Y, Hansen B C, Matsuzawa Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.  Diabetes. 2001;  50 1126-1133
  PubMedGoogle Scholar
• 27 Ezenwaka C E. Prospective study of offspring of Caribbean patients with type 2 diabetes: results of a 1-year follow-up study.  Canadian J Diabetes. 2003 ;  27(3) 248-255
  PubMedGoogle Scholar
• 28 Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipocyte specific protein, adiponectin in obesity.  Biochem Biophys Res Commun. 1999;  257 79-83
  CrossrefPubMedGoogle Scholar
• 29 Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Plasma concentration of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.  Arterioscler Thromb Vasc Biol. 2000;  20 1595-1599
  CrossrefPubMedGoogle Scholar
• 30 Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecule: adipocyte-derived plasma protein adiponectin.  Circulation. 1999;  100 2473-2476
  CrossrefPubMedGoogle Scholar
• 31 Scherer P E, Williams S, Fogliano M, Baldini G, Lodish H F. A novel serum protein similar to C1q produced exclusively in adipocytes.  J Biol Chem. 1995;  270 26 746-26 749
  PubMedGoogle Scholar

Dr. C. Ezenwaka

Unit of Pathology & Microbiology · Faculty of Medical Sciences · The University of the West Indies

St. Augustine · Trinidad

Phone: +1(868)663-6668

Fax: +1(868)663-3797

Email: ezenwaka@tstt.net.tt/ezenwaka@yahoo.com